High-dose riboflavin for migraine prophylaxis

source extracted confidence: high 2026-04-09
#cost-benefit-analysis #dose-response-relationship-drug #double-blind-method #drug-administration-schedule #family-practice

High-dose riboflavin for migraine prophylaxis

Mattimoe et al., 1998 | J Fam Pract | Rct

Citation

Mattimoe D, Newton W. High-dose riboflavin for migraine prophylaxis. J Fam Pract. 1998-Jul;47(1):11

Abstract

No abstract available

Key Findings

Requires manual extraction from full text

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • Cost-Benefit Analysis
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Family Practice
  • Humans
  • Migraine Disorders
  • Riboflavin
  • Treatment Outcome

Evidence Classification

  • Level: Rct
  • Publication Types: Clinical Trial, Journal Article, Randomized Controlled Trial
  • Vertical: riboflavin

Provenance

  • PMID: 9673596
  • DOI: (not available)
  • PMCID: Not in PMC
  • Verified: 2026-04-10 via PubMed E-utilities API

Source extracted via PubMed E-utilities API on 2026-04-10